Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis

Table 1

Baseline clinical characteristics of all patients ().

	Baseline
Age (years)	67.72 ± 0.48
Body mass index (kg/m^2)	24.23 ± 0.25
Serum calcium (mg/dL)	9.46 ± 0.02
Urinary calcium (mg/24 h)	169.00 ± 6.48
Serum phosphate (mg/dL)	3.84 ± 0.03
25(OH)vitamin D (ng/mL)	33.98 ± 0.73
iPTH (pg/mL)	46.80 ± 1.01
tAP (IU/L)	149.40 ± 5.65
BGP (ng/mL)	19.33 ± 0.75
s-CTX (ng/L)	332.40 ± 14.39
Lumbar spine BMD (g/cm^2; -score)	0.864 ± 0.006; −2.70 ± 0.06
Femoral neck BMD (g/cm^2; -score)	0.742 ± 0.006; −2.38 ± 0.05
Total hip BMD (g/cm^2; -score)	0.747 ± 0.006; −2.17 ± 0.05